[EN] SREBP INHIBITORS COMPRISING A THIOPHENE CENTRAL RING<br/>[FR] INHIBITEURS DE SREBP COMPRENANT UN ANNEAU CENTRAL DE THIOPHÈNE
申请人:CAPULUS THERAPEUTICS LLC
公开号:WO2022020738A1
公开(公告)日:2022-01-27
Provided herein are compounds comprising a three-ring core and pharmaceutically acceptable salts, solvates, tautomers, isotopes, or isomers thereof. Also provided herein are methods of inhibiting a component of the sterol regulatory element binding protein (SREBP) pathway, such as an SREBP or SREBP cleavage activating protein (SCAP), using these compounds, or pharmaceutically acceptable salts, solvates, tautomers, isotopes, or isomers thereof. Further provided are methods of treating a disorder in a subject in need thereof, such as liver disease, non-alcoholic steatohepatitis, insulin resistance, or cancer.
本文提供了包含三环核心和药用可接受盐、溶剂合物、互变体、同位素或异构体的化合物。本文还提供了使用这些化合物或药用可接受盐、溶剂合物、互变体、同位素或异构体来抑制类固醇调节元件结合蛋白(SREBP)途径的组分的方法,如SREBP或SREBP裂解活化蛋白(SCAP)。此外,还提供了治疗需要的受试者的疾病的方法,如肝病、非酒精性脂肪肝病、胰岛素抵抗或癌症。